BioCentury
ARTICLE | Company News

AstraZeneca sells dental business for $1.8B

June 23, 2011 12:51 AM UTC

AstraZeneca plc (LSE:AZN; NYSE:AZN) sold its dental and urological products division Astra Tech AB to Dentsply International Inc. (NASDAQ:XRAY) for $1.8 billion in cash. Astra Tech reported worldwide ...